DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine.

Jérôme Moreaux; Angelique Bruyer; Jean-Luc Veyrune; Hartmut Goldschmidt; Dirk Hose; Bernard Klein

doi:10.1111/bjh.12660

Journal articles

DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine.

Jérôme Moreaux ^{1, 2} Angelique Bruyer ¹ Jean-Luc Veyrune ^{1, 2} Hartmut Goldschmidt ^{3, 4} Dirk Hose ^{3, 4} Bernard Klein ^{1, *}

* Corresponding author

1 Cellules souches normales et cancéreuses

2 IRB - Institut de recherche en biothérapie

3 Department of Internal Medicine V

4 NCTD - National Center for Tumor Diseases

Abstract : -

Keywords : drug sensitivity prediction epigenetics myeloma gene expression gene arrays

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadatas

Cited literature [3 references] Display Hide Download

https://www.hal.inserm.fr/inserm-00906054
Contributor : Monique Frei <>
Submitted on : Tuesday, November 19, 2013 - 10:48:52 AM
Last modification on : Friday, May 15, 2020 - 12:22:03 PM
Long-term archiving on: : Saturday, April 8, 2017 - 1:31:17 AM

DNAmethylationJMnov2013.pdf

Files produced by the author(s)

DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine.

File

Identifiers

Collections

Citation

Export

Metrics

210

340

DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine.

File

Identifiers

Collections

Citation

Export

Share

Metrics

210

340